Takeda’s research and development (R&D) programs focus on the following therapeutic areas: Gastrointestinal and Inflammation, Neuroscience, Oncology, and Rare Genetics and Hematology. In addition, we make targeted R&D investments in plasma‑derived therapies and vaccines.
Our goal is to develop innovative medicines that expand existing treatment options and make a meaningful difference in the lives of people affected by these conditions.
Visit our website: https://www.takeda.com/science/pipeline/